Status:

UNKNOWN

Radiation Therapy in Treating Women Who Have Undergone Breast Conservation Surgery and Systemic Therapy for Early Breast Cancer

Lead Sponsor:

Institute of Cancer Research, United Kingdom

Conditions:

Breast Cancer

Eligibility:

FEMALE

18+ years

Phase:

PHASE3

Brief Summary

RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Specialized radiation therapy, such as intensity-modulated radiation therapy, that delivers a high dose of radiation directly ...

Detailed Description

OBJECTIVES: * To test dose-escalated intensity-modulated radiotherapy after breast conservation surgery in women with early breast cancer who are at higher than average risk for local recurrence. OU...

Eligibility Criteria

Inclusion

  • DISEASE CHARACTERISTICS:
  • Histologically confirmed invasive breast cancer
  • Resectable, unilateral disease
  • T1-3, N0-1, M0 disease
  • Has undergone prior breast conservation surgery with complete microscopic resection AND received appropriate systemic therapy for early breast cancer
  • Requires a tumor bed boost plus whole breast radiotherapy as indicated by ≥ 1 of the following:
  • Age 18-49 years
  • Tumor size \> 2.0 cm after primary surgery (maximum microscopic diameter of invasive component)
  • Tumor of any size treated by primary medical therapy
  • Grade III disease
  • Minimum microscopic margin of noncancerous tissue \< 5 mm (excluding deep margin if at deep fascia)
  • Lymphovascular invasion
  • Axillary node positive
  • Hormone receptor status not specified
  • PATIENT CHARACTERISTICS:
  • Menopausal status not specified
  • No prior malignancy other than non-melanoma skin cancer or carcinoma in situ of the cervix
  • PRIOR CONCURRENT THERAPY:
  • See Disease Characteristics
  • No prior mastectomy
  • No concurrent chemotherapy except primary or sequential chemotherapy

Exclusion

    Key Trial Info

    Start Date :

    August 1 2008

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    Estimated Enrollment :

    840 Patients enrolled

    Trial Details

    Trial ID

    NCT00818051

    Start Date

    August 1 2008

    Last Update

    January 7 2011

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Royal Marsden - Surrey

    Sutton, England, United Kingdom, SM2 5PT